KFF Health News chief Washington correspondent Julie Rovner discussed a proposed weight loss drug rule by the Centers for Medicare & Medicaid Services on CBS News’ “CBS News 24/7” on Nov. 26. KFF ...

In addition to Semaglutide, Orlistat is another weight-loss drug available in the Chinese market. Medication is among the approaches China's national health authority recommended in a recently ...

Innovent Biologics has announced the inclusion of its drug Sintbilo (tafolecimab injection) and a new indication for Olverembatinib in China’s National Reimbursement Drug List for 2024 ...

Their results, published in Neuron, identify crucial shared pathways, confirming that the Alzheimer's in a dish model can be used to assess new drugs accurately and rapidly as well as point the way to ...

Known as 'Alzheimer's in a dish,' the model uses cultures of mature brain cells suspended in a gel to recapitulate ... we've created a system that transforms how we discover and test drugs." ...

According to statistical reports, in 2023, expenditures from China's basic medical insurance, work-related injury insurance, and maternity insurance funds on drugs listed in the NRDL accounted for 90% ...

This development follows their exclusive licensing agreement with Revance Therapeutics to import, use, and commercialize the drug in China, Hong Kong, and Macau. This approval marks a significant ...

Their results identify crucial shared pathways, confirming that the Alzheimer's in a dish model can be used to assess new drugs accurately and rapidly as well as point the way to drug discovery.

Already, the researchers have tested hundreds of approved drugs and natural products using the Alzheimer's in a dish model, setting the stage for clinical trials. "Now we have a system that not ...

Their results, published in Neuron, identify crucial shared pathways, confirming that the Alzheimer's in a dish model can be used to assess new drugs accurately and rapidly as well as point the ...